(Q43716774)

26 November 2017

title

Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype (English)

1 reference

26 November 2017

1 reference

1 reference

Milde-Langosch K

1

1 reference

26 November 2017

Bamberger AM

2

1 reference

26 November 2017

Rieck G

3

1 reference

26 November 2017

Kelp B

4

1 reference

26 November 2017

Löning T

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Breast Cancer Research and Treatment

26 November 2017

published in

1 reference

26 November 2017

volume

67

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

61-70

1 reference

Analysis of p16 gene deletion and point mutation in breast carcinoma

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010623308275

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010623308275

Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010623308275

Hypomethylation and increased gene expression of p16INK4a in primary and metastatic breast carcinoma as compared to normal breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010623308275

CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010623308275

Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010623308275

P16/MTS1 and pRB expression in endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010623308275

Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010623308275

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010623308275

Cyclin E, a redundant cyclin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010623308275

Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010623308275

inferred from DOI database lookup

7 January 2021

based on heuristic

p16/MTS1 inactivation in ovarian carcinomas: high frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010623308275

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1023/A:1010623308275

1 reference

Dimensions Publication ID

26 November 2017

1040381205

0 references

1 reference